Literature DB >> 16002400

Beta-amyloid-induced dynamin 1 depletion in hippocampal neurons. A potential mechanism for early cognitive decline in Alzheimer disease.

Brent L Kelly1, Robert Vassar, Adriana Ferreira.   

Abstract

Synaptic dysfunction is one of the earliest events in the pathogenesis of Alzheimer disease (AD). However, the molecular mechanisms underlying synaptic defects in AD are largely unknown. We report here that beta-amyloid (Abeta), the main component of senile plaques, induced a significant decrease in dynamin 1, a protein that is essential for synaptic vesicle recycling and, hence, for memory formation and information processing. The Abeta-induced dynamin 1 decrease occurred in the absence of overt synaptic loss and was also observed in the Tg2576 mouse model of AD. In addition, our results provided evidence that the Abeta-induced decrease in dynamin 1 was likely the result of a calpain-mediated cleavage of dynamin 1 protein and possibly the down-regulation of dynamin 1 gene expression. These data suggest a mechanism to explain the early cognitive loss without a major decline in synapse number observed in AD and propose a novel therapeutic target for AD intervention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002400      PMCID: PMC1364535          DOI: 10.1074/jbc.M503259200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

Review 1.  Alzheimer's disease is a synaptic failure.

Authors:  Dennis J Selkoe
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

2.  Neurochemical markers do not correlate with cognitive decline in the Lewy body variant of Alzheimer disease.

Authors:  M N Sabbagh; J Corey-Bloom; P Tiraboschi; R Thomas; E Masliah; L J Thal
Journal:  Arch Neurol       Date:  1999-12

3.  Activation of dynamin I gene expression by Sp1 and Sp3 is required for neuronal differentiation of N1E-115 cells.

Authors:  Jiyun Yoo; Moon-Jin Jeong; Byoung-Mog Kwon; Man-Wook Hur; Young-Mee Park; Mi Young Han
Journal:  J Biol Chem       Date:  2002-01-23       Impact factor: 5.157

4.  Maintained synaptophysin immunoreactivity in Tg2576 transgenic mice during aging: correlations with cognitive impairment.

Authors:  David L King; Gary W Arendash
Journal:  Brain Res       Date:  2002-02-01       Impact factor: 3.252

5.  Potentiation of evoked vesicle turnover at individually resolved synaptic boutons.

Authors:  T A Ryan; N E Ziv; S J Smith
Journal:  Neuron       Date:  1996-07       Impact factor: 17.173

6.  The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease.

Authors:  P Tiraboschi; L A Hansen; M Alford; E Masliah; L J Thal; J Corey-Bloom
Journal:  Neurology       Date:  2000-11-14       Impact factor: 9.910

7.  Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.

Authors:  Jean-Cosme Dodart; Kelly R Bales; Kimberley S Gannon; Stephen J Greene; Ronald B DeMattos; Chantal Mathis; Cynthia A DeLong; Su Wu; Xin Wu; David M Holtzman; Steven M Paul
Journal:  Nat Neurosci       Date:  2002-05       Impact factor: 24.884

8.  Activation of c-Jun N-terminal kinase and p38 in an Alzheimer's disease model is associated with amyloid deposition.

Authors:  Mary J Savage; Yin-Guo Lin; John R Ciallella; Dorothy G Flood; Richard W Scott
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

9.  Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling.

Authors:  Ottavio V Vitolo; Antonino Sant'Angelo; Vincenzo Costanzo; Fortunato Battaglia; Ottavio Arancio; Michael Shelanski
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-20       Impact factor: 11.205

10.  Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice.

Authors:  H N Dawson; A Ferreira; M V Eyster; N Ghoshal; L I Binder; M P Vitek
Journal:  J Cell Sci       Date:  2001-03       Impact factor: 5.285

View more
  56 in total

1.  β-Amyloid carrying the Dutch mutation has diverse effects on calpain-mediated toxicity in hippocampal neurons.

Authors:  Alexandra M Nicholson; Lindsey A Wold; Dominic M Walsh; Adriana Ferreira
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

2.  Inhibition of calpain prevents NMDA-induced cell death and beta-amyloid-induced synaptic dysfunction in hippocampal slice cultures.

Authors:  V Nimmrich; K G Reymann; M Strassburger; U H Schöder; G Gross; A Hahn; H Schoemaker; K Wicke; A Möller
Journal:  Br J Pharmacol       Date:  2010-03-03       Impact factor: 8.739

Review 3.  Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets.

Authors:  Ying C Li; Ege T Kavalali
Journal:  Pharmacol Rev       Date:  2017-04       Impact factor: 25.468

4.  Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons.

Authors:  B L Kelly; A Ferreira
Journal:  Neuroscience       Date:  2007-05-17       Impact factor: 3.590

5.  Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients.

Authors:  Xinglong Wang; Bo Su; Hisashi Fujioka; Xiongwei Zhu
Journal:  Am J Pathol       Date:  2008-07-03       Impact factor: 4.307

6.  The novel calpain inhibitor A-705253 potently inhibits oligomeric beta-amyloid-induced dynamin 1 and tau cleavage in hippocampal neurons.

Authors:  Roxana C Sinjoanu; Sara Kleinschmidt; Robert S Bitner; Jorge D Brioni; Achim Moeller; Adriana Ferreira
Journal:  Neurochem Int       Date:  2008-06-12       Impact factor: 3.921

7.  Dynamins at a glance.

Authors:  Jürgen A W Heymann; Jenny E Hinshaw
Journal:  J Cell Sci       Date:  2009-10-01       Impact factor: 5.285

8.  Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure.

Authors:  Jorge Parodi; Fernando J Sepúlveda; Jorge Roa; Carlos Opazo; Nibaldo C Inestrosa; Luis G Aguayo
Journal:  J Biol Chem       Date:  2009-11-13       Impact factor: 5.157

9.  Identification of small molecule inhibitors of beta-amyloid cytotoxicity through a cell-based high-throughput screening platform.

Authors:  K I Seyb; E R Schuman; J Ni; M M Huang; M L Michaelis; M A Glicksman
Journal:  J Biomol Screen       Date:  2008-09-23

Review 10.  Amyloid-Beta and Phosphorylated Tau Accumulations Cause Abnormalities at Synapses of Alzheimer's disease Neurons.

Authors:  Ravi Rajmohan; P Hemachandra Reddy
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.